Revvity | PKI - PE价格收益



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 14.39B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


Pe 更改 日
Agilent 20.53 4.51 2026-03
Align Technology 21.8 0.98 2026-06
Bio Techne 38.75 81.27 2026-03
Bio-Rad Laboratories 48.85 38.84 2026-06
Bruker 46.54 9.74 2026-06
Celltrion 58.97 8.86 2026-03
Charles River Laboratories 58.27 29 2026-06
Cspc Pharmaceutical 23.62 0.78 2026-03
Danaher 32.68 3.4 2026-06
Dentsply International 20.31 9.68 2026-03
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 58.35 1.4 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Illumina 48.98 16.53 2026-06
Intuitive Surgical 44.59 11.23 2026-06
IQVIA Holdings 21.45 2.08 2026-06
Kangmei Pharma 1.11K 2.04K 2026-03
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Laboratory Of America 20.47 5.04 2026-06
Malin Corporation 11.81 0.72 2023-06
Mettler Toledo International 27.29 0.04 2026-06
Neuren Pharmaceuticals 72.14 59.86 2025-12
OraSure Technologies 24.42 12.6 2024-09
Organigram Holdings 12.01 222.99 2026-03
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 16.35 2.78 2026-06
Qiagen NV 16.72 2.76 2026-06
Quest Diagnostics 21.23 1.17 2026-06
Quidel 2.03 70.39 2025-12
Repligen 105.09 4.39 2026-06
Revvity 36.47 5.68 2026-06
Sartorius 52.99 9.56 2026-06
Sino Biopharmaceutical 17.03 0.89 2025-06
Thermo Fisher Scientific 26.4 1.31 2026-06
Tilray 11.56 80.19 2025-09
Waters 66.69 36.94 2026-06
Zealand Pharma A/S 3.27 1.86 2026-03
Zz Pientze Pharmaceu 47.68 1.35 2026-03